Improving the Quality of HIV Service Delivery and other Priority Public Health Interventions through Training Support for Epidemiology, Monitoring and Evaluation (M&E), Survey and Laboratory Services in Nigeria under the President’s Emergency Plan | CDC RFA GH16 164202CONT17

Opportunity Information: Apply for CDC RFA GH16 164202CONT17

This funding opportunity is a continuation cooperative agreement from the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), specifically through CDCs Center for Global Health. It sits under the President's Emergency Plan for AIDS Relief (PEPFAR) and focuses on strengthening the quality of HIV service delivery in Nigeria by supporting training and capacity-building in several technical areas that are essential to a high-performing public health response. The central idea is not simply to fund direct service delivery, but to improve how HIV and other priority public health programs are planned, measured, and improved over time by building skilled teams and stronger systems in epidemiology, monitoring and evaluation (M&E), survey methods, and laboratory services.

Because it is a cooperative agreement, the award structure typically implies substantial involvement from CDC in technical direction, collaboration, and oversight rather than a traditional grant where the recipient operates more independently. The opportunity is categorized as continuation funding, meaning it is intended to extend or continue work that has already been underway rather than launching an entirely new initiative. The funding activity category is listed as Health, and the CFDA number attached is 93.067, which corresponds to CDC global health-related assistance programs.

The program purpose, as reflected in the title and description, is to improve the quality of HIV service delivery and also support other priority public health interventions through training support. In practical terms, this kind of award generally backs activities such as developing and delivering structured training programs, mentoring and supportive supervision, strengthening data systems and data use, standardizing survey and surveillance approaches, and improving laboratory quality systems. Epidemiology support usually relates to strengthening the ability to collect and interpret disease data, investigate outbreaks, track trends, and translate findings into action. M&E support typically centers on improving routine reporting, data quality assurance, indicator definition and consistency, performance monitoring, and building a culture of using data for continuous quality improvement. Survey support commonly involves training in design and implementation of population-based or facility-based assessments, sampling, questionnaire development, field operations, and analysis, often to fill key information gaps that routine program data cannot address. Laboratory services support often includes training related to testing quality, proficiency, biosafety, quality management systems, and ensuring laboratory results are reliable enough to guide clinical and program decisions.

Although the opportunity is anchored in HIV, it explicitly mentions "other priority public health interventions," which signals an intent to build capacity that can benefit broader health security and disease control goals in Nigeria. Strengthening epidemiology, M&E, and laboratory systems tends to have cross-cutting value, improving the countrys ability to respond not only to HIV but also to outbreaks and ongoing public health challenges by improving surveillance, measurement, and diagnostic capability.

Administrative details in the source data indicate the opportunity number is CDC RFA GH16-164202CONT17. The expected number of awards is 10, suggesting multiple recipients or multiple funded partners continuing work in different geographic areas, technical components, or institutional settings. The listing shows an award ceiling of 0, which usually indicates that a specific maximum amount was not stated in the summary field, not necessarily that there is no funding. In many federal postings, award amounts and ceilings are either provided elsewhere in the full announcement or vary based on continuation funding decisions, performance, and availability of funds. The opportunity was created on February 6, 2017, with an original closing date of April 6, 2017.

Eligibility is summarized as "Others (see text field entitled Additional Information on Eligibility for clarification)," which implies the detailed eligibility rules were provided in the full announcement rather than in this excerpt. In CDC cooperative agreements, eligible applicants can often include government entities, public or private non-profits, universities, research institutions, and sometimes other organizations that meet specific criteria, particularly those with demonstrated capacity to implement health systems strengthening and technical training activities at scale.

Overall, this opportunity is best understood as a PEPFAR-linked CDC effort to raise the technical and operational quality of HIV programs in Nigeria by investing in the workforce and systems that make programs measurable, accountable, and continually improvable. The emphasis on training for epidemiology, M&E, surveys, and laboratories points to a comprehensive approach: strengthening the evidence pipeline from data collection and diagnostics, to analysis and interpretation, to practical program improvements in clinics and communities.

• The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Improving the Quality of HIV Service Delivery and other Priority Public Health Interventions through Training Support for Epidemiology, Monitoring and Evaluation (M&E), Survey and Laboratory Services in Nigeria under the President’s Emergency Plan" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
• This funding opportunity was created on Feb 06, 2017.
• Applicants must submit their applications by Apr 06, 2017. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 10 candidate(s).
• Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).

Apply for CDC RFA GH16 164202CONT17

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: